查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
大分子生物分析測試服務市場規模,份額和趨勢分析報告：按階段（臨床前,臨床）,研究類型（ADME,PD）,用戶,類型,治療領域,細分市場預測2022-2030
市場調查報告書
商品編碼
1133328

大分子生物分析測試服務市場規模,份額和趨勢分析報告：按階段（臨床前,臨床）,研究類型（ADME,PD）,用戶,類型,治療領域,細分市場預測2022-2030

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Test Type (ADME, PD), By End-user, By Type, By Therapeutic Areas, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10個工作天內

價格

大分子生物分析檢測服務市場增長及趨勢

根據 Grand View Research, Inc. 的一份新報告，到 2030 年，全球大分子生物分析測試服務市場規模預計將達到 35 億美元，在預測期內的複合年增長率為 9.1%。在生物標誌物、大分子和其他物質的臨床試驗中越來越多地使用生物分析測試是該行業的主要驅動力。新興國家慢性病發病率的上升和對臨床試驗需求的增加是推動市場增長的因素。例如，根據世界衛生組織的數據，2020 年將有大約 1000 萬人死於癌症。癌症估計表明，到 2040 年，將有 3020 萬人被診斷出患有癌症。其他方面，例如不斷增長的生物製劑、對先進技術的高需求以及對個性化孤兒藥和藥物的需求，預計將推動這一細分市場的增長。

此外，技術進步、臨床試驗全球化以及對 CRO 進行臨床試驗的需求不斷增長等因素預計將加速該行業的擴張。然而，大型製藥和生物分析公司因 COVID-19 大流行而面臨挑戰，擾亂了臨床研究和治療。除了 COVID-19 項目的工作量外，包括啟動臨床試驗、臨床前研究、生物分析以及與監管機構的互動，現場工作人員的流失也是一個困難來源。用於支持 Covid 試驗的生物分析、臨床前和臨床試驗的非 Covid 工作和資源的延遲導致了 4-6 個月的漫長等待時間。我們還必須解決哪些檢測與 Covid 相關哪些不是。

大分子生物分析測試服務市場報告亮點

2021年全球行業以臨床領域為主。新興國家慢性病的流行和對臨床試驗需求的增加預計將推動該領域的增長

2021年ADA板塊將主導全球行業，佔總收入的最大份額

由於仿製藥製造的採用率增加，生物利用度將在 2021 年擁有最大的測試部分份額

由於全球癌症患病率上升，腫瘤領域將在 2021 年佔據最大的收入份額

由於醫療保健支出增加，尤其是在印度和中國，預計亞太地區將在預測期內見證最快的複合年增長率

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 步
    • 類型
    • 測試類型
    • 治療區
    • 最終用戶
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析（模型一）
      • 方法一：商品流動方法
    • 批量定價分析（模型 2）
      • 方法 2：體積分析
  • 二級信息列表
  • 主要信息列表
  • 目的

第二章執行摘要

  • 市場展望

3. 大分子生物分析測試服務市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司的市場前景
    • 相關/子公司市場展望
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力分析
      • 越來越關注分析測試
      • 製藥和生物製藥行業的研發支出不斷增加
      • 外包
    • 市場約束分析
      • 外包
  • 大分子生物分析檢測服務市場分析工具
    • 行業分析 - 搬運工
    • PESTEL 分析
    • 市場進入策略
  • COVID-19 影響分析
    • COVID-19 恢復分析
  • 重大交易及戰略聯盟分析

第 4 章大分子生物分析測試服務市場：相位估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年大分子生物分析測試服務的市場份額
  • 細分儀表板
  • 全球大分子生物分析檢測服務市場分階段展望
  • 2018-2030 年大分子生物分析測試服務市場規模和預測及趨勢分析
    • 臨床前
      • 有抗體
      • 無抗體（（基於ELISA的測定）
    • 臨床

第 5 章大分子生物分析測試服務市場：按類型劃分的估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年大分子生物分析測試服務的市場份額
  • 細分儀表板
  • 按類型分列的全球大分子生物分析測試服務市場展望
  • 2018-2030 年大分子生物分析測試服務市場規模和預測及趨勢分析
    • 藥代動力學
    • ADA
    • 其他

第 6 章大分子生物分析測試服務市場：測試類型的估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年大分子生物分析測試服務的市場份額
  • 細分儀表板
  • 全球大分子生物分析測試服務市場展望（按測試類型）
  • 2018-2030 年大分子生物分析測試服務市場規模和預測及趨勢分析
    • ADME
    • PD
    • 生物利用度
    • 生物等效性
    • 其他測試

第7章按治療領域劃分的大分子生物分析檢測服務市場估計及趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年大分子生物分析測試服務的市場份額
  • 細分儀表板
  • 全球大分子生物分析檢測服務市場展望（按治療領域）
  • 2018-2030 年大分子生物分析測試服務市場規模和預測及趨勢分析
    • 腫瘤學
    • 感染
    • 心髒病學
    • 神經病學
    • 其他

第 8 章按最終用戶估計和趨勢分析的大分子生物分析測試服務市場

  • 定義和範圍
  • 2021 年和 2030 年大分子生物分析測試服務的市場份額
  • 細分儀表板
  • 按最終用戶展望的全球大分子生物分析測試服務市場
  • 2018-2030 年大分子生物分析測試服務市場規模和預測及趨勢分析
    • 中小企業
      • CRO 和 CMO
      • 贊助機構
      • 其他
    • 大公司
      • CRO 和 CMO
      • 贊助機構
      • 其他

第 9 章大分子生物分析檢測服務市場：區域估計和趨勢分析

  • 2021 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 10 章 競爭格局

  • 主要市場參與者的最新發展和影響分析
    • 科文斯
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • IQVIA
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • Syneous Health
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • SGS、SA
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • Toxikon
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • Intertek Plc
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • Pace Analytical Services LLC
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • ICON PLC
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • Charles River Laboratories
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
    • ThermoFisher Scientific
      • 公司簡介
      • 財務績效
      • 服務基準
      • 戰略舉措
Product Code: GVR-4-68038-979-1

Large Molecule Bioanalytical Testing Services Market Growth & Trends:

The global large molecule bioanalytical testing services market size is expected to reach USD 3.5 billion by 2030, registering a CAGR of 9.1% over the forecast period, according to a new report by Grand View Research, Inc. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Large Molecule Bioanalytical Testing Services Market Report Highlights:

  • The clinical segment dominated the global industry in 2021. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth
  • The ADA-type segment dominated the global industry in 2021 and accounted for the largest share of the overall revenue
  • Bioavailability was the largest test segment share in 2021 on account of the increasing adoption in generic drug manufacturing
  • The oncology segment held the largest revenue share in 2021 due to the increasing prevalence of cancer globally
  • Asia Pacific is projected to witness the fastest CAGR during the forecast years due to the rising healthcare expenditure, particularly in India and China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Phase
    • 1.1.2. Type
    • 1.1.3. Test Type
    • 1.1.4. Therapeutic Areas
    • 1.1.5. End User
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing focus on the analytical testing
      • 3.3.1.2. Growing R & D expenditure in the pharmaceutical and biopharmaceutical industries
      • 3.3.1.3. Rising demand for outsourcing of analytical testing
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Compliance issues while outsourcing
  • 3.4. Large Molecule Bioanalytical Testing Services Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTEL Analysis
    • 3.4.3. Market Entry Strategies
  • 3.5. COVID - 19 Impact Analysis
    • 3.5.1. COVID - 19 recovery analysis
  • 3.6. Major Deals & Strategic Alliances Analysis

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Large Molecule Bioanalytical Testing Services Market by Phase Outlook
  • 4.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Preclinical
      • 4.5.1.1. Preclinical market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.2. With Antibody
      • 4.5.1.2.1. With Antibody market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.3. Without Antibody ((ELISA Based Assay)
      • 4.5.1.3.1. Without Antibody (ELISA Based Assay) market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Clinical
      • 4.5.2.1. Clinical market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Large Molecule Bioanalytical Testing Services Market by Type Outlook
  • 5.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Pharmacokinetics
      • 5.5.1.1. Pharmacokinetics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. ADA
      • 5.5.2.1. ADA market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Others
      • 5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Large Molecule Bioanalytical Testing Services Market by Test Type Outlook
  • 6.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. ADME
      • 6.5.1.1. ADME market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. PD
      • 6.5.2.1. PD market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Bioavailability
      • 6.5.3.1. Bioavailability market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Bioequivalence
      • 6.5.4.1. Bioequivalence market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Other Tests
      • 6.5.5.1. Other Tests market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Outlook
  • 7.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Oncology
      • 7.5.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Infectious Diseases
      • 7.5.2.1. Infectious Diseases market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Cardiology
      • 7.5.3.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.4. Neurology
      • 7.5.4.1. Neurology market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.5. Others
      • 7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Large Molecule Bioanalytical Testing Services Market by End - user Estimates & Trend Analysis

  • 8.1. Definitions and Scope
  • 8.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 8.3. Segment Dashboard
  • 8.4. Global Large Molecule Bioanalytical Testing Services Market by End User Outlook
  • 8.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.5.1. SMEs
      • 8.5.1.1. SMEs market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.1.2. CROs & CMOs
      • 8.5.1.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.1.3. Sponsor Organizations
      • 8.5.1.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.1.4. Others
      • 8.5.1.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.2. Large Firms
      • 8.5.2.1. Large Firms market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.2.2. CROs & CMOs
      • 8.5.2.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.2.3. Sponsor Organizations
      • 8.5.2.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.2.4. Others
      • 8.5.2.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 9.1. Regional market share analysis, 2021 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. North America Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. U.S. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Canada Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. U.K.
      • 9.4.1.1. U.K. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Germany Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. France Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Italy Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Spain Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Japan Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. China Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. India Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.4. Thailand
      • 9.5.4.1. Thailand Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. South Korea Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Brazil Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.2. Mexico
      • 9.6.2.1. Mexico Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Argentina Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.4. Colombia
      • 9.6.4.1. Colombia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. South Africa Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Saudi Arabia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. UAE Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. 8.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 10.1.1. Covance
      • 10.1.1.1. Company overview
      • 10.1.1.2. Financial Performance
      • 10.1.1.3. Service benchmarking
      • 10.1.1.4. Strategic initiatives
    • 10.1.2. IQVIA
      • 10.1.2.1. Company overview
      • 10.1.2.2. Financial performance
      • 10.1.2.3. Service benchmarking
      • 10.1.2.4. Strategic initiatives
    • 10.1.3. Syneous Health
      • 10.1.3.1. Company overview
      • 10.1.3.2. Financial performance
      • 10.1.3.3. Service benchmarking
      • 10.1.3.4. Strategic initiatives
    • 10.1.4. SGS, SA
      • 10.1.4.1. Company overview
      • 10.1.4.2. Financial performance
      • 10.1.4.3. Service benchmarking
      • 10.1.4.4. Strategic initiatives
    • 10.1.5. Toxikon
      • 10.1.5.1. Company overview
      • 10.1.5.2. Financial performance
      • 10.1.5.3. Service benchmarking
      • 10.1.5.4. Strategic initiatives
    • 10.1.6. Intertek Plc
      • 10.1.6.1. Company overview
      • 10.1.6.2. Financial performance
      • 10.1.6.3. Service benchmarking
      • 10.1.6.4. Strategic initiatives
    • 10.1.7. Pace Analytical Services LLC
      • 10.1.7.1. Company overview
      • 10.1.7.2. Financial performance
      • 10.1.7.3. Service benchmarking
      • 10.1.7.4. Strategic initiatives
    • 10.1.8. ICON PLC
      • 10.1.8.1. Company overview
      • 10.1.8.2. Financial performance
      • 10.1.8.3. Service benchmarking
      • 10.1.8.4. Strategic initiatives
    • 10.1.9. Charles River Laboratories
      • 10.1.9.1. Company overview
      • 10.1.9.2. Financial performance
      • 10.1.9.3. Service benchmarking
      • 10.1.9.4. Strategic initiatives
    • 10.1.10. ThermoFisher Scientific
      • 10.1.10.1. Company overview
      • 10.1.10.2. Financial performance
      • 10.1.10.3. Service benchmarking
      • 10.1.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Large molecule bioanalytical testing services market snapshot (2021)
  • Fig. 10 Large molecule bioanalytical testing services market segmentation
  • Fig. 11 Heat map analysis
  • Fig. 12 Parent market outlook
  • Fig. 13 Ancillary market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Large molecule bioanalytical testing services market phase outlook: Segment dashboard
  • Fig. 20 Large molecule bioanalytical testing services market: Phase movement analysis
  • Fig. 21 Preclinical market, 2018 - 2030 (USD Million)
  • Fig. 22 With antibody market, 2018 - 2030 (USD Million)
  • Fig. 23 Without antibody market, 2018 - 2030 (USD Million)
  • Fig. 24 Clinical market, 2018 - 2030 (USD Million)
  • Fig. 25 Large molecule bioanalytical testing services market type outlook: Segment dashboard
  • Fig. 26 Large molecule bioanalytical testing services market: Type movement analysis
  • Fig. 27 Pharmacokinetics market, 2018 - 2030 (USD Million)
  • Fig. 28 Anti-Drug Antibodies (ADA) market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Large molecule bioanalytical testing services market test type outlook: Segment dashboard
  • Fig. 31 Large molecule bioanalytical testing services market: Test type movement analysis
  • Fig. 32 ADME testing market, 2018 - 2030 (USD Million)
  • Fig. 33 PD market, 2018 - 2030 (USD Million)
  • Fig. 34 Bioavailability market, 2018 - 2030 (USD Million)
  • Fig. 35 Bioequivalence market, 2018 - 2030 (USD Million)
  • Fig. 36 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 37 Large molecule bioanalytical testing services market therapeutic area outlook: Segment dashboard
  • Fig. 38 Large molecule bioanalytical testing services market: Therapeutic area movement analysis
  • Fig. 39 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 40 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 41 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 42 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 43 Others market, 2018 - 2030 (USD Million)
  • Fig. 44 Large molecule bioanalytical testing services market end-user outlook: Segment dashboard
  • Fig. 45 Large molecule bioanalytical testing services market: End-User movement analysis
  • Fig. 46 SMEs market, 2018 - 2030 (USD Million)
  • Fig. 47 CROs & CMO market, 2018 - 2030 (USD Million)
  • Fig. 48 Sponsor organization market, 2018 - 2030 (USD Million)
  • Fig. 49 Others market, 2018 - 2030 (USD Million)
  • Fig. 50 Large firms market, 2018 - 2030 (USD Million)
  • Fig. 51 CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 52 Sponsor organizations market, 2018 - 2030 (USD Million)
  • Fig. 53 Others market, 2018 - 2030 (USD Million)
  • Fig. 54 Regional market: Key takeaways
  • Fig. 55 Large molecule bioanalytical testing services market: Regional movement analysis
  • Fig. 56 North America. market, 2018 - 2030 (USD Million)
  • Fig. 57 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 58 Canada market, 2018 - 2030 (USD Million)
  • Fig. 59 Europe market, 2018 - 2030 (USD Million)
  • Fig. 60 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 61 Germany market, 2018 - 2030 (USD Million)
  • Fig. 62 France market, 2018 - 2030 (USD Million)
  • Fig. 63 Italy market, 2018 - 2030 (USD Million)
  • Fig. 64 Spain market, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 66 Japan market, 2018 - 2030 (USD Million)
  • Fig. 67 China market, 2018 - 2030 (USD Million)
  • Fig. 68 India market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 73 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 75 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 79 UAE market, 2018 - 2030 (USD Million)